Investing Profile

Dan Becker

InvestorVC

Managing Director at Access Biotechnology

accessbio-tech.comNew York, New York
Photo of Dan Becker, Managing Director at Access Biotechnology

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Access Biotechnology Managing Director
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
ACELYRIN
Series CSep 2022$300M
$560M
Co-investors: Richard Gaster (venBio), Beth Seidenberg (Westlake Village BioPartners), Sean Harper
Curie Therapeutics
Series ADec 2021$75M
$75M
Co-investors: Kevin Bitterman (Atlas Venture)
DTx Pharma
Series BMar 2021$100M
$110M
Co-investors: Andrew Adams (Oak HC/FT)
Day One Biopharmaceuticals
Series BFeb 2021$130M
Series AMay 2020$60M
$190M
Co-investors: Julie Grant (Canaan Partners), Michael Gladstone (Atlas Venture), Derek DiRocco (RA Capital)
Pandion Therapeutics
Series BApr 2020$80M
$140M
Co-investors: Alan Crane (Polaris Partners), Carlo Rizzuto (Versant Ventures), Vikas Goyal (SR One)
Neurana Pharmaceuticals
Series AMay 2018$60M
$60M
Co-investors: David Kabakoff (HealthQuest Capital)